418 filings
ARS
2023 FY
SPRO
Spero Therapeutics Inc
16 Apr 24
Annual report to shareholders
4:19pm
DEFA14A
SPRO
Spero Therapeutics Inc
16 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
SPRO
Spero Therapeutics Inc
Definitive proxy
16 Apr 24
4:11pm
8-K
SPRO
Spero Therapeutics Inc
29 Mar 24
Other Events
4:06pm
EFFECT
SPRO
Spero Therapeutics Inc
25 Mar 24
Notice of effectiveness
12:15am
S-3
SPRO
Spero Therapeutics Inc
Shelf registration
15 Mar 24
4:34pm
S-8
SPRO
Spero Therapeutics Inc
15 Mar 24
Registration of securities for employees
4:18pm
10-K
2023 FY
SPRO
Spero Therapeutics Inc
Annual report
13 Mar 24
4:10pm
8-K
SPRO
Spero Therapeutics Inc
13 Mar 24
Spero Therapeutics Announces Fourth Quarter and Full Year 2023
4:07pm
SC 13G
SPRO
Spero Therapeutics Inc
14 Feb 24
Spero Therapeutics / Anson Funds Management ownership change
4:25pm
8-K
SPRO
Spero Therapeutics Inc
9 Feb 24
Departure of Directors or Certain Officers
4:05pm
4
Timothy Keutzer
5 Feb 24
Spero Therapeutics / Timothy Keutzer ownership change
8:53pm
4
Mahadevia Ankit
5 Feb 24
Spero Therapeutics / Ankit Mahadevia ownership change
8:50pm
4
SPRO
Spero Therapeutics Inc
5 Feb 24
Spero Therapeutics / TAMARA L JOSEPH ownership change
8:48pm
4
Kamal Hamed
5 Feb 24
Spero Therapeutics / KAMAL HAMED ownership change
8:45pm
4
Esther Rajavelu
5 Feb 24
Spero Therapeutics / Esther Rajavelu ownership change
8:44pm
4
Sath Shukla
5 Feb 24
Spero Therapeutics / Sath Shukla ownership change
8:40pm
144
Sath Shukla
5 Feb 24
Notice of proposed sale of securities
4:50pm
8-K
SPRO
Spero Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
6:07am
8-K
SPRO
Spero Therapeutics Inc
5 Jan 24
Spero Therapeutics Provides Corporate Update and 2024 Outlook
8:11am